6.25
price down icon0.95%   -0.06
after-market Dopo l'orario di chiusura: 6.28 0.03 +0.48%
loading
Precedente Chiudi:
$6.31
Aprire:
$6.36
Volume 24 ore:
29,028
Relative Volume:
0.27
Capitalizzazione di mercato:
$23.02M
Reddito:
-
Utile/perdita netta:
$-31.11M
Rapporto P/E:
-4.085
EPS:
-1.53
Flusso di cassa netto:
$-28.18M
1 W Prestazione:
-6.30%
1M Prestazione:
-8.76%
6M Prestazione:
-47.95%
1 anno Prestazione:
-74.15%
Intervallo 1D:
Value
$6.22
$6.39
Intervallo di 1 settimana:
Value
$6.20
$6.7999
Portata 52W:
Value
$5.3495
$28.34

Tempest Therapeutics Inc Stock (TPST) Company Profile

Name
Nome
Tempest Therapeutics Inc
Name
Telefono
415-798-8589
Name
Indirizzo
2000 SIERRA POINT PARKWAY, BRISBANE
Name
Dipendente
5
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
TPST's Discussions on Twitter

Confronta TPST con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TPST
Tempest Therapeutics Inc
6.25 23.24M 0 -31.11M -28.18M -1.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-10 Downgrade H.C. Wainwright Buy → Neutral
2025-04-10 Downgrade Scotiabank Sector Outperform → Sector Perform
2024-03-14 Iniziato Scotiabank Sector Outperform
2024-02-08 Iniziato Jefferies Buy

Tempest Therapeutics Inc Borsa (TPST) Ultime notizie

pulisher
Jul 23, 2025

Is Tempest Therapeutics Inc. a good long term investmentSuperior stock growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Tempest Therapeutics Inc. Stock Analysis and ForecastExplosive wealth accumulation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Tempest Therapeutics Inc. stockBreakout stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives Tempest Therapeutics Inc. stock priceTriple-digit wealth increases - Autocar Professional

Jul 21, 2025
pulisher
Jul 18, 2025

Is Tempest Therapeutics Inc. stock a growth or value playSmart High Yield Swing Trades - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

Why Tempest Therapeutics Inc. stock attracts strong analyst attentionPrecision Entry Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Tempest Therapeutics Inc. stock performs during market volatilityFree Real-Time Trading Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Tempest Therapeutics Inc. stock price move sharplyFree Access to Community - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Head-To-Head Contrast: Tempest Therapeutics (NASDAQ:TPST) vs. Relmada Therapeutics (NASDAQ:RLMD) - Defense World

Jul 09, 2025
pulisher
Jul 05, 2025

Tempest Therapeutics (NASDAQ:TPST) Trading Up 0.2% – Here’s Why - Defense World

Jul 05, 2025
pulisher
Jul 02, 2025

Tempest Therapeutics’ Promising Advances in Liver Cancer Treatment - TipRanks

Jul 02, 2025
pulisher
Jun 30, 2025

Tempest Receives Clearance to Proceed with Pivotal Trial of - GlobeNewswire

Jun 30, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Acquires Shares of 189,506 Tempest Therapeutics, Inc. (NASDAQ:TPST) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Tempest Therapeutics Secures $4.1M in Direct Offering - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

SEC Form 424B5 filed by Tempest Therapeutics Inc. - Quantisnow

Jun 12, 2025
pulisher
Jun 12, 2025

Form 424B5 Tempest Therapeutics, - StreetInsider

Jun 12, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics Announces $4.6 Mln Registered Direct Offering With Institutional Investor - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics (TPST) Announces New Stock Purchase Agreeme - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics ends ATM prospectus with Jefferies By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics, Inc. Announces $4.6 Million Registered Direct Offering of Common Stock - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics announces $4.6 million registered direct offering - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics ends ATM prospectus with Jefferies - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics Terminates ATM Prospectus Supplement Dated February 6, 2025SEC Filing - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics Raises $4.6M From Single Institutional Investor: Strategic Alternative Process Funded - Stock Titan

Jun 11, 2025
pulisher
Jun 09, 2025

Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 09, 2025
pulisher
Jun 09, 2025

Pre-market Movers: KLTO, TPST, PYPD, MOVE... - RTTNews

Jun 09, 2025
pulisher
Jun 06, 2025

Tempest Therapeutics Shifts Executives to Consulting Roles - TipRanks

Jun 06, 2025
pulisher
Jun 05, 2025

Tempest Therapeutics stock rises on EMA Orphan Drug Designation By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Tempest Therapeutics stock rises on EMA Orphan Drug Designation - Investing.com

Jun 05, 2025

Tempest Therapeutics Inc Azioni (TPST) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):